RockHealth puts out a report that lists companies that received funding and there are several interesting points in that report for 2017.
In their list of megadeals – those companies that received more than $100M in funding, it is interesting that the companies are distributed throughout and not just the two coasts. One of the reasons is that these companies are affecting healthcare with most of the dollars going towards consumer health information and clinical decision support targeting electronic health records though interestingly many small deals also targeting the non-clinical workflow.
They also make a good point that none of the digital health company raised money on the public markets as opposed to Biotech’s and Biology technology companies of which there were several IPO’s last year.